Drug Trial Radar · NCT04669600
A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)
Last checked: Nov 19, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Feb 4, 2021
Primary completion
Feb 15, 2022
Study completion Feb 7, 2023
Sponsor
- Lead sponsor
- Bioverativ, a Sanofi companySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Dec 17, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: \- To evaluate the effect of BIVV020 on the durability of platelet response in participants with persistent/chronic immune thrombocytopenia (ITP) Secondary Objectives: * To assess the safety and tolerability of BIVV020 * To assess the pharmacokinetics of BIVV020 * To assess the response rate of treatment with BIVV020 * To assess the time to response * To assess the effect of treatment with BIVV020 on the requirement for rescue ITP therapy * To assess the immunogenicity of BIVV020
Conditions
- Immune Thrombocytopenia (ITP)
Interventions
SAR445088 (BIVV020)Drug
Pharmaceutical form:solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With a Durable Platelet ResponseTime frame: From Week 3 to Week 24
Locations
9 sites in 6 countries. Site status is shown where the registry gives one.
Investigational Site Number :8400001
Washington D.C., District of Columbia
Investigational Site Number :8400002
Tamarac, Florida
Investigational Site Number :2030002
Ostrava - Poruba, Czechia
Investigational Site Number :2760001
Essen, Germany
Investigational Site Number :5280001
Leiden, Netherlands
Investigational Site Number :7240001
Palma de Mallorca, Spain
Investigational Site Number :7240003
Seville, Spain
Investigational Site Number :7240002
A Coruña, A Coruña [La Coruña], Spain
Investigational Site Number :8260002
London, London, City of, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.